Towards Healthcare
AI in Cardiology Market Envisioned at USD 20.35 Billion by 2032

AI in Cardiology Market Envisioned at USD 20.35 Billion by 2032

Status: Published Category: Healthcare IT Insight Code: 5077 Format: PDF / PPT / Excel

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global AI in Cardiology Market Assessment

  • Overview
  • Global AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Services
  • Global AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiac Arrhythmias
    • Stroke
    • Ischemic Heart Disease/CAD
    • Others
  • Global AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa (MEA)

North America AI in Cardiology Market Assessment

  • Overview
  • North America AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Services
  • North America AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiac Arrhythmias
    • Stroke
    • Ischemic Heart Disease/CAD
    • Others

Europe AI in Cardiology Market Assessment

  • Overview
  • Europe AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Services
  • Europe AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiac Arrhythmias
    • Stroke
    • Ischemic Heart Disease/CAD
    • Others

Asia-Pacific AI in Cardiology Market Assessment

  • Overview
  • Asia-Pacific AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Services
  • Asia-Pacific AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiac Arrhythmias
    • Stroke
    • Ischemic Heart Disease/CAD
    • Others

Latin America AI in Cardiology Market Assessment

  • Overview
  • Latin America  AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Services
  • Latin America AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiac Arrhythmias
    • Stroke
    • Ischemic Heart Disease/CAD
    • Others

Middle East & Africa (MEA) AI in Cardiology Market Assessment

  • Overview
  • Middle East & Africa (MEA) AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Services
  • Middle East & Africa (MEA) AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiac Arrhythmias
    • Stroke
    • Ischemic Heart Disease/CAD
    • Others

Company Profiles

  • Philips
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Siemens Healthineers
  • Medtronic Johnson & Johnson
  • Google Health
  • Microsoft Healthcare
  • Ultromics Limited
  • CardiAl I
  • IBM Watson Health
  • IDOVEN

Conclusion & Recommendations

  • Insight Code: 5077
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: December 2023
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

The rising prevalence of cardiovascular diseases, including CAD, IHD, and strokes, has indeed led to an increased demand for AI detection methods in cardiology, driving market growth. AI technologies offer promising advancements in early diagnosis and personalized treatment planning for cardiovascular conditions. Continuous advancements in machine learning algorithms, data analytics, and imaging technologies contribute to more accurate and efficient cardiovascular disease detection and management. This innovation-driven progress enhances the overall effectiveness of AI applications in cardiology.

The North America dominate globally is expected to see a 41 percent increase in heart disease related medical costs between 2010 and 2040, from USD 126.2 billion to USD 177.5 billion. Some of the factors driving this upward trend include the regions expanding number of new artificial intelligence product approvals by regulators, a strong healthcare system and the rapid adoption of cutting edge products.

Key market players, including Philips, Siemens Healthineers, Medtronic, Johnson & Johnson, Google Health, Microsoft Healthcare, Ultromics Limited, CardiAl, IBM Watson Health, and IDOVEN, are key market players contributing significantly to the growth of AI in cardiology. Their research, development, and integration of AI technologies in diagnostic tools and healthcare systems play a pivotal role in advancing cardiological practices.

World Health Organisation, Food and Drug Administration, National Institute of Health, European Parliamentary Research Service, American College of Cardiology Foundation, British Heart Foundation, Center for Disease Control and Prevension.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 509

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 509